HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Temporal changes of CB1 cannabinoid receptor in the basal ganglia as a possible structure-specific plasticity process in 6-OHDA lesioned rats.

Abstract
The endocannabinoid system has been implicated in several neurobiological processes, including neurodegeneration, neuroprotection and neuronal plasticity. The CB1 cannabinoid receptors are abundantly expressed in the basal ganglia, the circuitry that is mostly affected in Parkinson's Disease (PD). Some studies show variation of CB1 expression in basal ganglia in different animal models of PD, however the results are quite controversial, due to the differences in the procedures employed to induce the parkinsonism and the periods analyzed after the lesion. The present study evaluated the CB1 expression in four basal ganglia structures, namely striatum, external globus pallidus (EGP), internal globus pallidus (IGP) and substantia nigra pars reticulata (SNpr) of rats 1, 5, 10, 20, and 60 days after unilateral intrastriatal 6-hydroxydopamine injections, that causes retrograde dopaminergic degeneration. We also investigated tyrosine hydroxylase (TH), parvalbumin, calbindin and glutamic acid decarboxylase (GAD) expression to verify the status of dopaminergic and GABAergic systems. We observed a structure-specific modulation of CB1 expression at different periods after lesions. In general, there were no changes in the striatum, decreased CB1 in IGP and SNpr and increased CB1 in EGP, but this increase was not sustained over time. No changes in GAD and parvalbumin expression were observed in basal ganglia, whereas TH levels were decreased and the calbindin increased in striatum in short periods after lesion. We believe that the structure-specific variation of CB1 in basal ganglia in the 6-hydroxydopamine PD model could be related to a compensatory process involving the GABAergic transmission, which is impaired due to the lack of dopamine. Our data, therefore, suggest that the changes of CB1 and calbindin expression may represent a plasticity process in this PD model.
AuthorsGabriela P Chaves-Kirsten, Caio H Y Mazucanti, Caroline C Real, Bruna M Souza, Luiz R G Britto, Andréa S Torrão
JournalPloS one (PLoS One) Vol. 8 Issue 10 Pg. e76874 ( 2013) ISSN: 1932-6203 [Electronic] United States
PMID24116178 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Calbindins
  • Receptor, Cannabinoid, CB1
  • Oxidopamine
  • Tyrosine 3-Monooxygenase
Topics
  • Animals
  • Basal Ganglia (metabolism)
  • Calbindins (metabolism)
  • Globus Pallidus (metabolism)
  • Immunoblotting
  • Immunohistochemistry
  • Male
  • Neostriatum (metabolism)
  • Oxidopamine
  • Parkinsonian Disorders (chemically induced, metabolism)
  • Rats
  • Rats, Wistar
  • Receptor, Cannabinoid, CB1 (metabolism)
  • Substantia Nigra (metabolism)
  • Time Factors
  • Tyrosine 3-Monooxygenase (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: